← Eichor
Study identifier: NCT06299683 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment

Condition: Chronic Interstitial Cystitis · Bladder Pain Syndrome · Painful Bladder Syndrome  ·  Sponsor: Vanderbilt University Medical Center

PhaseNA
Planned participants220
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a severe pain condition affecting 3-8 million people in the United States lacking treatments that work. Emotional suffering is common in IC/BPS and known to make physical symptoms worse, and studies show patient sub-groups respond differently to treatment. Individuals with IC/BPS have distinct subgroups, or "phenotypes," largely characterized by the distribution of pain throughout the body. Supported by our preliminary evidence, the overall goal of this project is to assess how IC/BPS phenotype may affect response to two different therapies often given without regard to patient phenotype, pelvic floor physical therapy (PT) and cognitive-behavioral therapy (CBT) for IC/BPS.

This description comes directly from the study's public registry record.

Talk to the study team

Lindsey McKernan, PhD, MPH  ·  615-875-9990  ·  research.ocim@vumc.org

Always discuss trial participation with your own doctor first.

Locations (1)

Vanderbilt Urology Cool SpringsFranklin, Tennessee, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06299683